Fred Bader, retired former vice president, Johnson & Johnson
Adel Bakhtyari, senior analytical scientist, Paratek Pharmaceuticals [Added: 3:20 pm, 8/8/11]
Mary Lynn Baniecki, fellow, Harvard Medical School [Added: 2:25 pm, 8/10/10]
Kathleen Beach, director, GlaxoSmithKline
Joan Bell, global head, program office, Novartis
Dennis Benjamin, senior director, chemistry, Seattle Genetics
Leslie Benthien, director of global training, BioMarin Pharmaceuticals
David Berstein, senior vice president and chief intellectual property officer, Ariad Pharmaceuticals
Bernadine Blacknall (Kirkland), senior administrative associate, scientific alliances & research, global medical affairs, Millennium: The Takeda Oncology Company [Updated: 3:20 pm, 10/19/11]
Dale Blank, biotechnology consultant
Garen Bohlin, executive vice president, Constellation Pharmaceuticals
Page Bouchard, global head, preclinical safety, Novartis
Ron Branning, vice president, corporate quality assurance, Gilead Sciences
David Brazier, associate director, clinical operations, New England Research Institutes
Sue Brodeur, associate director, technical operations, Pfizer [Added: 1:35 pm, 3/25/10]
Jonathan Brooks, research scientist II, Pfizer [Added: 12:30 pm, 3/29/10]
Eugene (Gene) Brown, managing member, Quicksilver Consultants
Scott Brown, vice president, general counsel, Novartis Institutes for BioMedical Research [Added: 4:38 pm, 8/1/10]
Tim Bugbee, director, manufacturing, Pfizer [Added: 7:45 pm, 3/23/10]
Paul Burgess, vice president of intellectual property, BIND Biosciences, director of intellectual property, Logical Therapeutics [Added: 10:30 am, 3/26/10]
Kathy Byington, vice president, finance and administration, University of Maryland Baltimore [Added: 7:15 pm, 4/18/10]
Ray Camphausen, associate vice president, protein design, Adnexus Therapeutics
Barbara Carter, biotech human resources consultant
Martha Carter, senior vice president of regulatory affairs and quality assurance, Proteon Therapeutics
Anthony Celeste, research investigator, Array BioPharma [Added: 12:20 am, 4/23/10]
Catherine Celingant, senior director, medical systems innovative technologies, Millennium: The Takeda Oncology Company
Abbie Celniker, CEO, Taligen Therapeutics
Maria Cervone, informatics project manager, center for biomedical informatics, Harvard Medical School
Divya Chaudary, consultant, Nimbus Discovery [Added: 3:35 pm, 10/19/11]
Gustav Christensen, president and CEO, Dyax
Michael Cicio, senior director of manufacturing, Lonza Biologics
Chuck Cifuni, senior project manager, process transfer and manufacturing, pharmaceutical science R&D, Pfizer [Added: 11:35 am, 4/5/10]
Steve Clark, board member, Aveo Pharmaceuticals
Denis Clifford, vice president and chief marketing officer, SBLI
Gary Cohen, biotech attorney specializing in IP and ethics, Foundation Medicine
Robert Corcoran, vice president of quality operations, Shire Human Genetic Therapies
Richard Covitz, president, Oncology Partners
Lisa Cozza, senior director of manufacturing alliances, Human Genome Sciences
Lori Crane, non clinical development sciences, Millennium: The Takeda Oncology Company
Christopher Crowley, senior technology scientist II, Pfizer [Added: 2 pm, 4/2/10]
Luann Cserr, Principal, Cserr Patents & Strategic Counseling [Added: 11/23/10]
Cristina Csimma, vice president of drug development, Virdante Pharmaceuticals
